Search for Clinical Trial Results
Angioedema - 189 Studies Found
Status | Study |
Completed |
Study Name: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) Condition: Hereditary Angioedema Date: 2007-04-04 Interventions:
|
Completed |
Study Name: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema Condition: ACE-I and ARB-induced Angioedema. Date: 2016-07-05 |
Active, not recruiting |
Study Name: A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2011-06-28 Interventions: Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg |
Recruiting |
Study Name: Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema Condition: Acute ACE-induced Angioedema Date: 2013-04-26 Interventions:
|
Completed |
Study Name: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects Condition: Hereditary Angioedema Date: 2007-02-07 Interventions: Drug: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2007-02-21 Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2007-04-17 Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-07-29 Interventions:
|
Recruiting |
Study Name: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients Condition: Hereditary Angioedema Date: 2011-05-19 Interventions: Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The |
Completed |
Study Name: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) Condition: Hereditary Angioedema Date: 2007-04-04 Interventions: Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack |